Saint Francis Memorial Hospital | |
900 Hyde St, San Francisco, California 94109 | |
(415) 353-6000 | |
Name | Saint Francis Memorial Hospital |
---|---|
Type | Acute Care Hospital |
Location | 900 Hyde St, San Francisco, California |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 050152 |
NPI Number | 1316061997 |
Organization Name | SAINT FRANCIS MEMORIAL HOSPITAL |
Address | 900 Hyde St, San Francisco, CA 94109 |
Hospital Type | General Acute Care Hospital |
Phone Number | 415-353-6000 |
News Archive
Alizé Pharma III SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, today announces that it has acquired exclusive worldwide rights to develop and commercialize a new family of peptides with bone anabolic properties.
The Nano BioDiscovery™ Division of NanoInk®, Inc. announced today the release of a new automated platform for the analysis of its protein NanoArray assays. NanoInk's NanoArray Assay System™ enables detection, identification, and quantitation of clinically relevant, low abundance proteins from a wide variety of sample types for applications such as biomarker analysis, translational medicine, and toxicology.
BioAlliance Pharma SA today announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc (miconazole Lauriad), Mucoadhesive Buccal Tablets (MBT) developed for the treatment of OroPharyngeal Candidiasis in immunocompromised population. This trial was conducted to support an NDA filing to market the product in the US.
University of Kansas scientists have found that infants who were fed formula enriched with long-chain polyunsaturated fatty acids (LCPUFA) from birth to 12 months scored significantly better than a control group on several measures of intelligence conducted between the ages of three to six years.
› Verified 7 days ago
NPI Number | 1760257034 |
Organization Name | FRED B HOM MD INC |
Address | 900 Hyde St, San Francisco, CA 94109 |
Hospital Type | General Acute Care Hospital |
Phone Number | 415-479-6000 |
News Archive
Alizé Pharma III SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, today announces that it has acquired exclusive worldwide rights to develop and commercialize a new family of peptides with bone anabolic properties.
The Nano BioDiscovery™ Division of NanoInk®, Inc. announced today the release of a new automated platform for the analysis of its protein NanoArray assays. NanoInk's NanoArray Assay System™ enables detection, identification, and quantitation of clinically relevant, low abundance proteins from a wide variety of sample types for applications such as biomarker analysis, translational medicine, and toxicology.
BioAlliance Pharma SA today announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc (miconazole Lauriad), Mucoadhesive Buccal Tablets (MBT) developed for the treatment of OroPharyngeal Candidiasis in immunocompromised population. This trial was conducted to support an NDA filing to market the product in the US.
University of Kansas scientists have found that infants who were fed formula enriched with long-chain polyunsaturated fatty acids (LCPUFA) from birth to 12 months scored significantly better than a control group on several measures of intelligence conducted between the ages of three to six years.
› Verified 7 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Alizé Pharma III SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, today announces that it has acquired exclusive worldwide rights to develop and commercialize a new family of peptides with bone anabolic properties.
The Nano BioDiscovery™ Division of NanoInk®, Inc. announced today the release of a new automated platform for the analysis of its protein NanoArray assays. NanoInk's NanoArray Assay System™ enables detection, identification, and quantitation of clinically relevant, low abundance proteins from a wide variety of sample types for applications such as biomarker analysis, translational medicine, and toxicology.
BioAlliance Pharma SA today announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc (miconazole Lauriad), Mucoadhesive Buccal Tablets (MBT) developed for the treatment of OroPharyngeal Candidiasis in immunocompromised population. This trial was conducted to support an NDA filing to market the product in the US.
University of Kansas scientists have found that infants who were fed formula enriched with long-chain polyunsaturated fatty acids (LCPUFA) from birth to 12 months scored significantly better than a control group on several measures of intelligence conducted between the ages of three to six years.
› Verified 7 days ago
California Pacific Medical Ctr-davies Campus Hosp Acute Care Hospital Location: 601 Duboce Avenue, San Francisco, California 94117 Phone: (415) 600-6000 | |
California Pacific Medical Center- Van Ness Campus Acute Care Hospital Location: 1101 Van Ness Avenue, San Francisco, California 94109 Phone: (415) 600-6000 | |
California Pacific Medical Center - Mission Bernal Acute Care Hospital Location: 3555 Cesar Chavez Street, San Francisco, California 94110 Phone: (415) 641-6562 | |
Kaiser Foundation Hospital - San Francisco Acute Care Hospital Location: 2425 Geary Blvd, San Francisco, California 94115 Phone: (415) 833-2646 | |
Saint Francis Memorial Hospital Acute Care Hospital Location: 900 Hyde St, San Francisco, California 94109 Phone: (415) 353-6000 | |
Zuckerberg San Francisco General Hosp & Trauma Ctr Acute Care Hospital Location: 1001 Potrero Avenue, San Francisco, California 94110 Phone: (415) 206-8000 |